LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

Q2 2021 13F Holders as of 30 Jun 2021

Type / Class
Equity / COMMON STOCK
Shares outstanding
363,214,619
Total 13F shares
117,708,489
Share change
+818,560
Total reported value
$540,207,653
Put/Call ratio
76%
Price per share
$4.59
Number of holders
105
Value change
+$2,119,118
Number of buys
63
Number of sells
46

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) as of Q2 2021

As of 30 Jun 2021, LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX) was held by 105 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 117,708,489 shares. The largest 10 holders included Artal Group S.A., BVF INC/IL, FMR LLC, BlackRock Inc., VANGUARD GROUP INC, D. E. Shaw & Co., Inc., NEA Management Company, LLC, PINNACLE ASSOCIATES LTD, JPMORGAN CHASE & CO, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 105 institutional shareholders reporting positions in this security for the Q2 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.